関連する実験動画
Updated: Jul 10, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
S6K1の欠如は,年齢および食事による肥満から保護し,同時にインスリン感受性を高めます
Sung Hee Um1, Francesca Frigerio, Mitsuhiro Watanabe
1Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, 4058 Basel, Switzerland.
Nature
|August 13, 2004
まとめ
S6キナーゼ1 (S6K1) 欠乏症は,脂肪の分解を促進することによって,肥満から保護します. しかし,S6K1はインスリンシグナル伝達を否定的に調節し,特に脂肪が多い状態では,糖尿病の新たな治療標的を提供している.
科学分野:
- メタボリックシグナル伝達経路
- 肥満と糖尿病の研究
- ラパミシン (mTOR) 経路の哺乳類ターゲットである.
背景:
- 肥満はインスリン作用を低下させ,糖尿病に寄与します.
- S6キナーゼ1 (S6K1) は,栄養素とインスリン信号を統合する.
- ネズミのS6K1欠乏症は,グルコース不耐症やインスリン感受性の変化を含む複雑な代謝表型を示しています.
研究 の 目的:
- 代謝調節とインスリン感受性におけるS6K1の役割を調査する.
- 肥満に対するS6K1欠乏の影響と高脂肪食への反応を決定する.
- S6K1とインスリン抵抗性を結びつける分子メカニズムを解明する.
主な方法:
- S6K1欠乏したマウスの分析,通常の食事と高脂肪食の条件下.
- グルコースホメオスタシス,フリー脂肪酸レベル,ベータ酸化の評価.
- インスリン受容体基質1 (IRS1) がインスリン抵抗性の主要な部位でリン酸化する研究 (S307およびS636/S639)
主要な成果:
- S6K1欠乏したマウスは,ベータ酸化が強化されたため,食事による肥満から保護されています.
- 保護にもかかわらず,高脂肪食は,S6K1欠乏したマウスでは高血糖症とインスリン受容体の無敏感化につながる.
- S6K1欠乏症は,S307およびS636/S639におけるIRS1のリン酸化を阻害し,中断された負のフィードバックループを通じたインスリン感受性の保存を示す.
- 肥満の野生型および遺伝的肥満モデルでは,S6K1の活性が上昇し,IRS1のリン酸化が増加しています.
結論:
- S6K1は,栄養豊富な条件下でインスリンシグナル伝達を否定的に調節する上で重要な役割を果たします.
- S6K1-IRS1のネガティブなフィードバックループの障害は,インスリン過敏症に寄与する.
- S6K1の活性をターゲットにすることで,肥満と2型糖尿病の治療戦略を提供することができる.
関連する概念動画
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Other Disorders of Digestive System
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Sulfur Assimilation
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...

